Post-Approval Commitments and Phase 4 Clinical Trials in the U.S.
Post-Approval Commitments and Phase 4 Clinical Trials in the U.S. Understanding FDA Post-Approval Commitments and Phase 4 Clinical Trials in the United States Introduction FDA approval of a New Drug Application (NDA) or Biologics License Application (BLA) does not mark the end of clinical development. Sponsors are often required to conduct post-approval (Phase 4) studies…
Read More “Post-Approval Commitments and Phase 4 Clinical Trials in the U.S.” »